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Abstract
Due to their inherent structural plasticity, intrinsically disordered proteins (IDPs)
are generally difficult to characterise, both experimentally and via simulations. In this
work, an approach for studying IDPs within the potential energy landscape framework
is implemented and tested. Specifically, human CD4 receptor peptide, a disordered
region implicated in HIV-1 infection, is characterised via basin-hopping parallel tem-
pering and discrete path sampling. We also investigate the effects of three state-of-the-
art AMBER forcefields (ff99SB-ILDN, ff14ipq, and ff14SB) on the energy landscape.
The results for ff99SB-ILDN exhibit the best agreement with experiment. Metastable
states identified on the free energy surface help to unify, and are consistent with, several
earlier predictions, and may serve as starting points for probing the reaction interface
between CD4 and HIV-1 accessory proteins.
Introduction
In the mid-1990’s, the suggestion that many functional proteins were natively disordered was
met with much scepticism.1,2 This notion was in direct conflict with the linear sequence–
structure–function paradigm that had guided molecular biology for over half a century. Since
then, overwhelming evidence from experiment3–7 and bioinformatics surveys of entire genome
sequences8,9 have driven a paradigm shift, and the abundance and importance of intrinsically
disordered proteins (IDPs) or regions (IDRs) are now widely recognised. It has been esti-
mated that about 50% of mammalian proteins contain contiguous disordered regions (>30
residues long) and about 25% are fully disordered.10 Disordered sequences are generally
characterised by a low content of bulky hydrophobic amino acids, a high proportion of polar
and charged amino acids, and an overall low complexity (low complexity sequences contain
multiple repeats of single amino acids or amino acid motifs).4,11,12 Due to their composition,
IDPs usually do not collapse to form hydrophobic cores, or fold into stable three-dimensional
structures.1,7 Instead, under physiological conditions, they display a high degree of conforma-
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tional flexibility, in which several states rapidly interconvert.13,14 Accordingly, IDPs exhibit
diverse functional modes: in some cases, their functions depend directly on the disordered
state,5,15 while, in other instances, they undergo induced folding upon interaction with a
molecular partner.3,16,17
These characteristics confer several functional advantages to IDPs, such as the ability to
regulate distance and orientation of protein domains, bind to targets with high specificity
and low affinity, interact with multiple targets, and undergo post-translational modifications.
IDPs therefore play a central role in many fundamental processes, including transcription
regulation, translation, cell signalling and phosphorylation.7,15,18,19 On the other hand, in-
trinsic disorder in proteins “can also have a biological cost in terms of the promotion and
proliferation of protein folding diseases”.7 Specifically, the altered expression of IDPs has
been linked to several diseases,20 including cancer, diabetes, neurodegenerative diseases, and
cardiovascular diseases.21–26 Additionally, structural disorder has been associated with the
action of pathogens;1 for example, certain viruses may mimic IDRs and interfere with their
regulation inside the cell.27
Thus, characterisation of IDPs is an important research area, to elucidate their func-
tions and to identify potential therapeutic targets. Experimental characterisation of IDPs
via conventional techniques has proved to be challenging, largely due to the fact that these
methods were originally optimised for folded proteins. In particular, due to their dynamic
nature, the electron density of IDRs is often absent from X-ray diffraction maps.5 Addition-
ally, in standard NMR studies, IDPs usually form aggregates at the required experimental
concentrations, interconversion of conformational states leads to line-broadening effects, and
peaks corresponding to disordered proteins are often poorly dispersed.28 Techniques such as
near and far-UV circular dichroism (CD) have been employed to distinguish between folded
and disordered proteins. Since intrinsic disorder is commonly confined to a small region of
the protein, CD methods, which lack residue-specific information, need to be combined with
other techniques to properly characterise IDRs.5 Mutidimensional NMR approaches,28,29
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SAXS,30,31 single-molecule FRET32 and AFM33 have all proved useful in providing struc-
tural and dynamical information for disordered proteins. In one study, multidimensional
NMR was used in conjunction with isotopic labelling to probe IDPs in vivo.34 Other hybrid
approaches, such as protease digestion with mass spectrometry,35 have also been employed
to identify IDPs, albeit less effectively than NMR-based techniques.
Molecular simulations, which can provide high resolution structural and kinetic informa-
tion for IDP ensembles, have complemented experimental studies.36–39 In particular, these
simulations can provide predictions for experiment, or can be used in conjunction with
experiments to aid interpretation.40,41 The quality of such predictions and interpretations
depends primarily on the accuracy of protein force fields and on the efficiency of the sampling
strategy employed. As for conventional experimental techniques, protein force fields were
originally developed for folded globular proteins; thus, they may display secondary structure
biases.42,43 Hence, is its necessary to develop force fields that can achieve a good balance
among secondary structures. To this end, several standard force fields have been modified
and benchmarked for IDPs.44–51 While most modifications have led to improved performance,
several studies have yielded inconsistent results, and there is currently no general consensus
on the best force field for IDPs.
Since the conformational space of disordered proteins is significantly more complex and
heterogeneous than for globular proteins, enhanced sampling for IDPs is critical.52–54 Ac-
cordingly, various enhanced sampling schemes and algorithms have been employed, such as
temperature replica exchange molecular dynamics (tREMD),55 bias-exchange metadynamics
(BE-META),56–59 and Markov state models (MSMs).60–65 In replica exchange protocols the
protein undergoes a random walk, where information is exchanged between replicas period-
ically.66 Metadynamics based approaches may use experimental data to guide sampling,67
whereas in MSMs the goal is to probe long time dynamics by constructing kinetic models
from numerous (mainly short) unbiased MD simulations.68 This formalism is based on a
master equation approach, as in the present work. However, instead of molecular dynamics,
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we characterise states and interconversion rates using geometry optimisation, with post-
processing using tools of statistical mechanics and unimolecular rate theory. Several other
sampling approaches have been used to characterise IDP ensembles with varying degrees of
success,52–54 including some that utilise reweighing techniques.41
In the present work, the cytoplasmic tail of human cluster of differentiation 4 (CD4),
an IDR linked to HIV-1 infection, is investigated computationally.69 CD4 is a glycoprotein
(gp), mainly expressed on the surface of regulatory T cells (a subclass of white blood cells).70
The glycoprotein contains 433 residues and is made up of three regions: an extracellular
N-terminal region (371 residues), a transmembrane helix (24 residues) and a cytoplasmic C-
terminal domain (38 residues), Figure 1.69,71,72 The T cell receptors (TCR) are responsible
for recognising antigen peptides bound to Major Histocompatability Complex class II (MHC-
II) molecules. During this recognition process, CD4 functions as a coreceptor, whereby the
extracellular region binds to a region of MHC-II.73,74 Additionally, the cytoplasmic tail of
CD4 interacts with a lymphocyte-specific protein kinase (p56lck), by jointly coordinating
Zn2+ via a pair of cysteines on each molecule (residues 420 and 422 in CD4).75 Ultimately,
the interaction between CD4 and the TCR complex recruits p56lck to TCR (which induces
phosphorylation of TCR-associated molecules),76,77 and is a central upstream event in TCR
signal transduction and the immune response.
CD4 also acts as a primary receptor of human immunodeficiency virus type 1 (HIV-
1).78–81 Specifically, entry of HIV-1 into the T cells is initiated by binding of the glycoprotein
gp120 (on the HIV-1 envelope) to the extracellular region of CD4.82 This initial interaction
eventually leads to fusion of the viral and cell membranes and subsequent infection. Once
the cell has become infected, the presence of CD4 is known to interfere with the viral life
cycle;83,84 for example, CD4 may inhibit the release of nascent viruses.85,86 However, HIV-1
has evolved to produce viral proteins, Nef (negative factor) and Vpu (viral protein U), which
physically bind to and downregulate CD4 in T cells, ensuring viral proliferation.87,88
Co-immunoprecipitaion and mutational analyses suggest that residues 402–419 of CD4,
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located in the membrane-proximal region of the cytoplasmic tail, are necessary for HIV-1
viral protein-induced downregulation.89–92 Moreover, a putative amphipathic α-helix in that
region was found to be responsible for binding of both Nef and Vpu to CD4.91,93–96 The CD4
receptor peptide (residues 403–419) was characterised by CD and NMR spectroscopy, and
it was reported that residues 403–412 formed an α-helix, with an equilibrium population of
about 25%.97 In a recent simulation study, employing REMD and MSM building techniques,
it was demonstrated that the free energy landscape (FEL) for the receptor peptide (residues
402–419) was mainly flat—a characteristic feature of IDPs.98
Figure 1: NMR solution structure for the transmembrane and cytoplasmic domains of human
CD4 (PDB code: 2KLU).72 The CD4 receptor peptide (402–419) is highlighted in red.
Here, an alternative approach for modelling intrinsic disorder in proteins, based on the
potential energy landscape (PEL) framework,99–101 is presented. Specifically, geometry
optimisation-based approaches, namely basin-hopping parallel tempering (BHPT)102 and
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discrete path sampling (DPS),103–105 are utilised to explore the PEL and FEL for the CD4
receptor peptide (CD4RP). Recently, Chebaro et al.
106 used REMD and DPS to probe the
FEL for an IDR of the p53 upregulated modulator of apoptosis (PUMA) protein, and found
that the potential energy landscape was inherently multifunnelled. In other work, BHPT
was employed to predict favourable oligomers of amyloid β-peptide, Aβ1−42,102 implicated
in Alzheimer’s disease.
The BHPT–DPS approach combines structure prediction and network building for ef-
ficient sampling of IDPs. Using these tools, benchmarks are presented for CD4RP ensem-
bles generated with various state-of-the-art AMBER force fields (ff99SB-ILDN,45 ff14ipq,107
ff14SB108). AMBER force fields are widely used to model protein folding and there is an
ongoing need to examine their performance, particularly for IDPs. Since the PEL framework
offers an integrated approach for probing structure, dynamics and thermodynamics, along
with powerful landscape visualisation techniques,99 it can provide systematic comparisons
of IDP ensembles generated by different force fields. We found that ff99SB-ILDN achieves a
better balance of helical and random-coil structure for CD4RP than the more recent ff14ipq
and ff14SB parametrisations. The free energy landscape for CD4RP was computed for ff99SB-
ILDN, within the energy landscape framework, and various metastable states were identified.
These results unify previous conflicting experimental findings for CD4RP and account for the
rich functional repertoire of this intrinsically disordered region. Finally, we discuss the bio-
logical implications of our results relating to HIV-1 infection and opportunities for rational
drug design.
Methods
Preparation of initial structures
The NMR solution structures for human CD4 (403–419) were obtained from the Protein Data
Bank (PDB ID: 1WBR). All 32 models were extracted, and the missing arginine residue (402)
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was added using PyMOL.109 The N- and C-terminal ends of the peptide were capped with
an acetyl group and methylamide, respectively.
Force fields and solvent models
The performance of three AMBER force fields was tested in this study. AMBER ff99SB-
ILDN45 was developed to improve the side-chain torsion potentials of isoleucine, leucine,
aspartate and asparagine in AMBER ff99SB.42 Improvements of side-chain torsion poten-
tials for most amino acids, as well as backbone φ and ψ dihedral parameters, were later
implemented as AMBER ff14SB.108 Hence, these two force fields derive from the same par-
ent (AMBER ff94).110 In contrast, AMBER ff14ipq107 represents a full rederivation of torsion
parameters, coupled with the implicitly polarised charge (IPolQ) model111 for approximating
protein partial charges in the condensed phase.
Simulations of CD4RP (402–419) using the above force fields were performed with both
explicit and implicit solvent models. For the explicit solvent investigations, ff99SB-ILDN and
ff14SB force fields were paired with TIP3P,112 and ff14ipq was paired with TIP4P-Ew.113
The explicit solvent models were chosen to be consistent with the models used to parametrise
the respective force fields.
All implicit solvent simulations were conducted by coupling the force fields with GB-
Neck2114 (igb=8 in Sander). Maffucci and Contini51 reported that GB-Neck2 was able to
compensate for slight helical biases displayed by the ff99SB series. The ff99SB-ILDN/GB-
Neck2 combination was also able to discriminate helices from IDPs and reasonably predicted
β-hairpins in their study.51 An effective salt concentration of 0.1 M was maintained to provide
mobile counterions in solution, and a cutoff of 25 A˚ was used for computation of the effective
Born radius. The AMBER force fields were also correctly symmetrised,115 to ensure that
the energies of permutational isomers were identical.
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Structural refinement via MD
For each force field, the 32 initial structures were first minimised in vacuum for 8000 steepest-
descent (SD) steps, followed by 2000 steps using the conjugate gradient (CG) method. The
minimised structures were then solvated in an octahedral box, with a minimum distance of
12 A˚ between the peptide and the box edge. For each system, four Cl− ions were added
to neutralise the charges on the peptide. The solvated structures were then minimised for
10000 steps (8000 SD; 2000 CG) with a cutoff of 10 A˚ and periodic boundary conditions
for computing non-bonded interactions. A force constant of 100 kcal mol−1 A˚−2 was used to
restrain the peptide. The restraint was subsequently removed and the systems were allowed
to relax for a further 10000 steps, using the same minimisation protocol as before.
Each system was then heated to 300 K for 20 ps, and the temperature was regulated using
a Langevin thermostat with a collision frequency of 1 ps. A small restraint of 10 kcal mol−1 A˚−2
was imposed on the peptide, and bonds involving hydrogen were constrained using the
SHAKE algorithm, permitting an integration time step of 2 fs. The peptide restraints were
removed and 5 ns of constant pressure (1 atm) MD was carried out; followed by 2 ns of MD in
the canonical ensemble. Finally, 100 ns of MD in the NVT ensemble at 300 K was performed
for each system (i.e. an aggregate production time of 3.2µs for each force field). Frames
along the trajectories were saved every 10 ps. The lowest energy conformer from each MD
simulation (32 conformers per force field) was then selected to initiate structure prediction
runs via basin-hopping parallel-tempering (BHPT).
Structure prediction via BHPT
In BHPT, multiple basin-hopping (BH)116,117 runs for replicas at different temperatures are
performed simultaneously.102 As with other replica exchange methods, the lower temperature
limit for BHPT is usually chosen as the temperature at which physical observables are to
be evaluated, while the high temperature limit is selected to permit crossing of the highest
energy barriers on the landscape. After a given number of BH steps, replicas at adjacent
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temperatures may be exchanged, based on a Metropolis criterion for the energies of the
replicas.
In this work, the goal is not to locate the global potential energy minimum, since this
structure for IDPs is unlikely to dominate the equilibrium properties. Instead, BHPT was
utilised to explore the low energy regions of the potential energy landscape (PEL). The ex-
change of replicas in the BHPT procedure avoids kinetic trapping and facilitates accelerated
exploration and sampling of the conformational space.
For each CD4RP conformer, BHPT runs were conducted using 16 replicas at temperatures
exponentially distributed between 300 and 550 K using an implicit solvent representation.
Each BHPT run consisted of 5000 BH steps and exchanges among neighbouring replicas
were attempted every 10 steps. To explore the conformational space, random displacements
of Cartesian coordinates were used (with a maximum step size of 1 A˚) and step sizes were
adjusted to achieve an acceptance probability of 22%. The most stable conformer at 300 K
from each BHPT run was chosen as a starting point for construction of the PEL via discrete
path sampling (DPS).103–105
Construction of potential energy landscapes via DPS
Initial discrete paths between pairs of CD4RP conformers were first constructed. The starting
conformer pairs (endpoints) were aligned using the LPERMDIST procedure in OPTIM.118
This procedure effectively computes the minimised distance between endpoints with respect
to translation, rotation and permutation. The updated quasi-continuous interpolation (QCI)
scheme119 was then used to predict configurations between the two endpoints. The interpo-
lated geometries were then fed to the doubly-nudged120 elastic band121,122 (DNEB) routine,
producing a discrete set of images between the selected endpoints. Maxima along this pro-
file were then taken as initial transition state guesses. These candidates were then tightly
converged using the hybrid eigenvector-following (HEF) procedure.123,124 Refined transition
states were then connected to minima by following steepest-descent paths parallel and anti-
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parallel to the unique downhill direction. Minima were converged using a modified limited-
memory Broyden-Fletcher-Golgfarb-Shano (L-BFGS) algorithm125,126 with a convergence
condition of 10−7 kcal mol−1 A˚−1 for the root-mean-square gradient. The initial paths were
then optimised using the SHORTCUT127–129 and UNTRAP128 schemes in PATHSAMPLE130
to produce the final kinetic transition networks (KTNs).
Estimation of free energies and conversion pathways
The free energy landscape (FEL) was computed at 300 K using the harmonic superposition
approximation (HSA).131 Minima and transition states were first clustered into free energy
groups using a recursive lumping procedure (REGROUPFREE in PATHSAMPLE).132 The
conversion pathways between conformers were obtained by applying Dijkstra’s shortest path
algorithm127 to the clustered KTN.
Secondary structure analysis, computation of NMR shifts and coupling constants
Secondary structure analysis of minima in each transition network was conducted using the
DSSP program133 and NMR shifts were computed with ShiftX.134 To determine overall NMR
shifts, weighted sums, based on the equilibrium occupation probabilities, were calculated at
300 K for minima in the KTN.
Three-bond JHNHα coupling constants were computed using the Karplus equation:
3JHNHα(φ) = Acos
2(φ) +Bcos(φ) + C, (1)
A = 9.5, B = −1.4 and C = 0.3, as proposed by Bru¨schweiler and Case.135 Finally, the
potential energy landscapes (and free energy surfaces) were visualised using disconnectivity
graphs.136,137
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Results and Discussion
Low-lying conformers
The NMR solution structures for residues 403–419 of CD4 are depicted in Figure 2a. The
NMR-averaged ensemble displays notable structural variation, particularly in the C-terminal
region, and the conformers show some tendency to form α-helices between residues 403–
412, as reported earlier by Willbold and Ro¨sch.97 Each of the 32 structures in the NMR
ensemble were simulated via MD and subsequently BHPT using the three AMBER force
fields. Explicit solvent MD was used to probe regions of local stability on the potential
energy landscape of CD4RP. Seeding BHPT from MD trajectories is not strictly required,
since BHPT runs can be initiated from the prepared NMR structures themselves. However,
starting from locally stable regions on the PEL meant that fewer BHPT steps were required
to satisfactorily explore low-lying wells on the PEL. On average, the potential energy of
conformers improved by about 8 kcal mol−1 after BHPT, and the final 32 conformers covered
a range of less than 20 kcal mol−1 for each of the three force fields.
The BHPT predicted conformers from each force field are shown in Figure 2. It is evident
that ff99SB-ILDN and ff14ipq show greater structural variation than ff14SB. The conformers
for the first two force fields resemble molten globules, in which there is partial formation
of helical structure. Conversely, the final ensemble for ff14SB reveals significant helical
character, where the CD4RP forms linear helices. On average, contiguous α-helices nine,
seven, and eleven residues long were obtained for ff99SB-ILDN, ff14ipq, ff14SB respectively.
Notably, consistent with the NMR experiment, no antiparallel β-strands were seen.
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(a) NMR ensemble (403–
419) (b) ff99SB-ILDN
(c) ff14ipq
(d) ff14SB
Figure 2: Structural ensembles for human CD4 receptor peptide: (a) 32 NMR solution
structures (residues 403–419); (b)–(d) conformers (residues 402–419) obtained after BHPT,
using various AMBER force fields. The conformers were clustered using PyMOL and were
oriented with the N-terminal region on the left. The colouring scheme is: teal (helices),
salmon (loops).
Convergence of stationary point databases
The conformers in Figure 2b–2d were used to construct potential energy landscapes for
CD4RP via discrete path sampling. To test for convergence of the respective stationary point
databases, the constant volume heat capacity (Cv) curves were computed for subsets of the
local minima. In particular, Cv curves were derived for minima within a given threshold
above the global potential energy minimum (Figure 3). At low temperatures, we expect
that features in the heat capacity may be attributed to a small subset of local minima.
Hence, this approach should be robust in testing for convergence of the databases and should
be able to reveal any deficiencies in sampling. For the three force fields tested, the low-
temperature features in the heat capacity are converged when about 50% of all minima in
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the corresponding stationary point database are included. A summary of the number of local
minima and transition states in the final database for each force field is given in Table 1. In
the next section, the properties of the resulting potential energy landscapes for CD4RP are
compared systematically.
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Figure 3: Constant volume heat capacity curves (Cv) for human CD4 receptor peptide.
The curves were computed using the harmonic superposition approximation for the peptide
simulated by various AMBER force fields. Minima within a specified energy threshold of the
global potential energy minimum were incrementally included in the calculation of Cv. The
energy thresholds (kcal mol−1) and the corresponding fraction of minima in the database are
provided for each plot in parentheses.
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Table 1: Number of minima (MIN) and transition states (TS) in the DPS
databases for the CD4 receptor peptide modelled by various AMBER force fields
AMBER force field No. of MIN No. of TS
99SB-ILDN45 47434 51675
14ipq107 53926 58008
14SB108 67276 68689
Characterisation of potential energy landscapes
The potential energy landscape for CD4RP modelled by the ff99SB-ILDN force field is pre-
sented in Figure 4; it is distinctively multifunnelled, with several prominent low-lying fun-
nels. It was previously postulated that such multifunnelled potential energy landscapes are
characteristic features of intrinsically disordered proteins.106
The disconnectivity graphs in Figure 4 are coloured based on the secondary structure
content; specifically, the percent α-helical, random-coil, and turn structure are shown, since
these features were most common in the computed KTNs. The fractional α-helicity is best
able to classify the funnels on the landscape (Figure 4a). Many low energy conformers contain
linear α-helices, differing mainly in the length of the helical segment and orientation of side-
chain groups. The shortest α-helices in that region are about six residues long (approx. 1.7
turns), and the longest consists of 18 residues. Slightly higher in energy are conformers that
display helical propensities in the N- and C-terminal segments of the peptide. There are also
a number of conformers that lack α-helical structure and are quite low in energy.
Chebaro et al. found that for the PUMA peptide the contiguous α-helix was enthalpically
unstable and that low-lying minima were relatively unstructured.106 The organisation of the
PEL for PUMA strongly suggested that the interaction of this IDP with molecular partners
would mainly involve an induced-fit type mechanism. As mentioned above, the longest
contiguous α-helix (residues 402–419) in CD4RP corresponds to a low energy conformer on
the PEL. This result suggests that interactions involving direct binding to CD4RP are most
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likely to occur via conformational selection.
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8 kcalmol−1
(a) % α-helix
72
42
11
(b) % random-coil
78
39
0
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Figure 4: Potential energy landscape for CD4RP modelled by the AMBER 99SB-ILDN force
field. In the disconnectivity graphs, minima (branches) are coloured based on secondary
structure content. Selected structures are superimposed on the graph and the α-helical
segments are coloured in teal.
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The potential energy barriers between conformers exceeding 50% α-helical content are
much smaller than those separating conformers with residual helical content. The latter
conformers generally lie higher in energy and display greater coil-like and turn secondary
structure. Very few β-strand conformers were identified for the ff99SB-ILDN force field. For
this representation, the conformers generally show α-helical propensities, and only a few of
them are largely unstructured.
Figure 5 illustrates the potential energy landscape for CD4RP computed with the first-
generation ff14ipq force field. As for ff99SB-ILDN, the landscape is intrinsically disordered,
with multiple prominent funnels. However, the relative potential energy barriers between the
various low-lying conformers are notably larger than those obtained with ff99SB-ILDN. The
conformers for ff14ipq are also more heterogeneous than those located with ff99SB-ILDN.
The predicted linear α-helical motifs in CD4RP are also shorter, by about two residues, for
this force field. As before, conformers lacking significant helical structure, characterised
by turns (Figure 5c) and coil-like (Figure 5b) secondary structure, generally reside in the
high energy regions of the landscape. Additionally, a greater proportion of minima contain
random-coil character than observed for ff99SB-ILDN.
Finally, the landscape for CD4RP was probed using the ff14SB force field; the topology is
evidently less multifunnelled than for the former two force fields (Figure 6). Additionally, the
landscape is dominated by linear α-helical conformers. Secondary structure characterisation
also reveals regions with substantial coil-like structure (Figure 6b), separated from the main
part of the landscape by particularly high potential energy barriers. However, even in these
regions, conformers still exhibit some helical character. Similar regions were also identified
on the ff99SB-ILDN and ff14ipq landscapes, and the entropic barrier between them and the
other parts of the PEL is therefore likely to be physically realistic.
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Figure 5: Potential energy landscape for CD4RP modelled by the AMBER 14ipq force field.
In the disconnectivity graphs, minima (branches) are coloured based on secondary structure
content. Selected structures are superimposed on the graph in (a) and the α-helical segments
are coloured in teal.
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Figure 6: Potential energy landscape for CD4RP modelled by the AMBER 14SB force field.
In the disconnectivity graphs, minima (branches) are coloured based on secondary structure
content. Selected structures are superimposed on the graph in (a) and the α-helical segments
are coloured in teal.
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The distribution of the radius of gyration (Rg) for the local minima of CD4RP is shown in
Figure 7a. For all the force fields, there is a single peak in the Rg distribution. Conformers
generated with ff14SB are most extended (i.e., corresponding to linear helices), while those
predicted with ff14ipq are most compact (consistent with a greater presence of molten-
globule like structures on the landscape). A slightly broader Rg distribution is obtained for
ff99SB-ILDN, which peaks between the two newer AMBER force fields.
Figure 7b summarises the distribution of fractional α-helicity. All force fields show multi-
ple peaks in the distribution (at a bin width of 10%), with the major peaks for ff99SB-ILDN
and ff14SB at about 60–70% α-helicity. The distribution for ff14ipq is shifted to the left; in
general, ff14ipq predicts peptides with fewer helical residues than the other two force fields.
Additionally, on inspecting the left tails of the distributions, it is apparent that only a few
conformers located with f14SB lack α-helical character. The distributions for ff99SB-ILDN
and ff14SB are somewhat similar, although the former parametrisation predicts a greater
fraction of structures with low α-helical content.
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Figure 7: Distribution of radius of gyration (Rg) and fractional α-helicity for local minima
of CD4RP generated with various AMBER force fields, as indicated.
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NMR shifts and coupling constants
Predicted NMR shifts are a useful tool for validating simulation data by comparison with
experiment. The computed HN NMR shifts for human CD4 (residues 403–419) are pre-
sented in Figure 8. The agreement between the experimental and calculated NMR shifts
was assessed by computing
χ2σ =
1
N
N∑
i=1
(δi,cal − δi,exp)2
σ2δ
, (2)
where i is the residue number, N is the number of residues, δi,cal and δi,exp are the calculated
(as described earlier) and experimental chemical shifts, respectively, and σ2δ is the uncertainty
(σδ = 0.49 ppm for HN using SHIFTX). By definition, χ
2
σ > 1 indicates a significant difference
between computed and experimental structures.138 The χ2σ values for the HN NMR shifts for
ff99SB-ILDN, ff14ipq and ff14SB structures are 0.28, 0.55 and 0.42, respectively. Based on
this metric, the HN shifts for the ensembles generated with all three force fields agree quite
well with the experimental findings.97 The main deviations from the NMR experiments occur
in the C-terminal region of the peptide (residues 417–419); the de novo approach employed
in this work generally yields more ordered C-termini than found in experiment. In the N-
terminal part of the peptide, ff14SB predicted more structured helices, while ff14ipq predicts
more disorder than experiment. However, the overall HN NMR shifts, particularly those
computed for ff99SB-ILDN, closely match the literature values.
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Figure 8: Comparison of HN NMR shift for CD4RP ensembles generated with various AM-
BER force fields and experiment. The χ2σ uncertainty, which measures the agreement between
computed and experimental shifts, is given in parentheses.
In addition to NMR shifts, average 3JHNHα values (weighted by occupation probabilities
at 300 K) were computed for residues 403–419, and the root-mean-square deviation (rmsd)
of the calculated and experimental values was determined. For ff99SB-ILDN, ff14ipq and
ff14SB rms deviations of 1.40, 1.68 and 1.50 Hz were obtained, respectively. Overall, ff99SB-
ILDN performs best for CD4RP, in terms of reproducing the HN NMR shifts and J coupling
constants. This force field was therefore selected for further analysis, specifically for probing
the free energy surface.
Free energy landscape for CD4RP
The free energy landscape for CD4RP was produced by clustering minima and transition
states in the ff99SB-ILDN-derived kinetic transition network, based on the relative free
energy barriers. To cluster the stationary points, the lowest energy minima with highest
fractional random-coil and α-helical structure were taken as the starting configurations for
A (reactant) and B (product), respectively. Using a recursive regrouping scheme, A and
B were then expanded as free energy groups, based on a predefined free energy threshold
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(∆F ) at 300 K. The rate constant for the A → B conversion was derived by employing a
graph transformation procedure.139 To determine an appropriate value for ∆F , regrouping
was repeated for different values in the range 0 to 20 kcal mol−1, and the smallest threshold
(in this case, 5.5 kcal mol−1) for which the rate constant converged was chosen for probing
the free energy surface.
The resulting free energy landscape is depicted as a disconnectivity graph in Figure 9, and
representative structures for various free energy groups are superimposed on the graph. The
computed FEL is similar to the corresponding PEL in Figure 4. The lowest free energy group
at 300 K (g1) contains a contiguous α-helix extending from residues ALA404–SER415. Other
free energy groups, of comparable energies, also contain linear α-helical motifs: g2 (406–415),
g4 (403–419), g5 (402–415).
A putative amphipathic α-helix between residues 402–419 of the cytoplasmic tail of hu-
man CD4 may be necessary for interaction with both Nef and Vpu—HIV-1 accessory pro-
teins.91,93–96 Willbold and Ro¨sch predicted an α-helix from residues 403–412 for CD4RP.
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Putative α-helices extending from residues 402–417,69 406–415140 and 404–41371,72 have also
been reported for the cytoplasmic tail of human CD4. On the computed free energy surface,
these motifs are most similar to those found in g4, g2 and g9, respectively, which are all
low-lying states. These results suggest that CD4RP is capable of adopting a wide range of
helical motifs of varying lengths, which extend from different residues; however, the precise
α-helical structure observed is most likely dependent on the prevailing conditions or the res-
olution of the experiment. The results here help to unify previous experimental work, and
explain the ability of CD4RP to bind different molecular partners. Additionally, Wittlich and
collegues reported that the amphipathic helix was stable even at 45◦C.72 The free energy
landscape was also examined at 318 K (not shown) and is in agreement with those findings.
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Figure 9: Free energy disconnectivity graph for CD4RP modelled by the ff99SB-ILDN force
field. The free energy groups (branches) are coloured according to the α-helical content.
Representative structures of selected free energy groups are superimposed on the graph and
the α-helical motifs are coloured in teal.
The relatively high free energy barriers between the various α-helical states on the FEL
also suggest that conversion between them is likely to occur on long time scales. Furthermore,
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fully unstructured states are generally higher in energy on the FEL and it is unlikely that
CD4RP is unstructured under physiological conditions. Moreover, the intrinsic disorder in
this peptide may be accurately described as a tendency to adopt various ordered states
encompassing α-helical scaffolds. The dominance of these α-helical scaffolds in the low-
lying regions of the FEL suggests that interaction with molecular partners may occur via
conformational selection.
Folding mechanism for CD4RP
Figure 10: Folding pathway from a fully unstructured (A) state to a state containing a
contiguous α-helical structure 18 residues long (B) on the FEL for CD4RP. The number of
steps corresponds to the number of transition states on the discrete path.
To gain further insight into the folding dynamics of CD4RP the pathway from a fully unstruc-
tured state (g13) to a state containing the longest contiguous α-helix (g7; 18 residues long)
was examined (Figure 10). Folding from the ‘random-coil-like’ state occurs in a cooperative
fashion; i.e. there is a gradual decrease in the free energy of the states encountered as the
peptide folds. This result agrees well with the findings of Ahalawat and co-workers,98 who
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also reported that the formation of the helix began at residues 407–410.98 For the pathway
depicted in Figure 10, the helix initiates from a similar region (410–413). The N-terminal
portion folds first and several states on the pathway (between steps 8–12) exhibit α-helical
residues for the membrane proximal region (403–413) with an unstructured C-terminus. In-
terestingly, the helical motif in that segment of the path is almost identical in length and
position with the original experimental prediction (403–412). It appears that this scaffold is
an important structure for CD4RP function.
Finally, pathways and corresponding rate constants for conversions between various states
on the FEL were examined. Generally, the rate for folding from states with linear helical
motifs (e.g. g4, g9) to g1 is four to six orders of magnitude faster than from states without
helices (e.g. g10, g11, g13). However, the rate constant for interconversions of various ordered
helical scaffolds (e.g. g7 → g1) is of the order of 10−5 s−1, suggesting that these transforma-
tions may occur slowly. The free energy barriers for such interconversions may be lowered in
the presence of a molecular partner. Alternatively, different prevailing conditions in the cell
may favour one state over the another, explaining why several groups have reported differing
lengths for linear helical motifs for CD4RP.
Conclusions
Binding of HIV-1 glycoprotein gp120 to the extracellular domain of CD4 leads to exposure of
epitopes, which can be targeted by antibodies.141 However, the presence of HIV-1 accessory
proteins, Vpu and Nef, indirectly reduces the exposure of these epitopes by downregulat-
ing CD4 from the surface of infected cells.142,143 Several approaches for HIV-1 antiviral
drug design have focused on inducing exposure of HIV-1 epitopes, in the absence to CD4,
to promote antibody-mediated responses.144–147 These approaches adopt the conventional
structure-based drug design model, which is based on targeting well-defined regions in pro-
teins.148
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Recently, some researchers suggested that an alternative route for drug development could
be based on designing drugs that can mimic the interaction of the cytoplasmic tail of CD4
with HIV-1 accessory proteins, in an antagonistic fashion.147,149 Similar design principles
have already been adopted in cancer therapies, where small molecules that mimic intrinsi-
cally disordered regions have been used to inhibit critical protein-protein interactions.150,151
However, the development of CD4 cytoplasmic tail-mimicking molecules has been slower,
because the CD4–Vpu/Nef interaction site has been difficult to characterise.
In the present work, the free energy landscape for the CD4 receptor peptide has been
explored by employing geometry optimisation-based approaches. The metastable states we
have identified help to unify, and are consistent with, several earlier predictions. The con-
formers identified herein may be used as starting points in docking studies with HIV-1
accessory proteins, to better probe the recognition process. Additionally, the strategies pre-
sented in this work may be used to characterise the full-length cytoplasmic domain. These
investigations may prove useful, not only in achieving thorough characterisation of the reac-
tion interface, but may also represent critical step towards developing viable CD4 receptor
peptide mimetics.
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